ELOX — Eloxx Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Eloxx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -66.7 | -36.1 | -17.1 | -3.14 | -6 |
| Depreciation | |||||
| Non-Cash Items | 32.6 | 4.26 | 1.76 | 0.749 | -0.852 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.03 | -0.118 | 0.844 | -2.36 | 0.52 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -35 | -31.8 | -14.3 | -4.71 | -6.33 |
| Capital Expenditures | -0.089 | -0.066 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.15 | 0 | 0.309 | 0.038 | 0.001 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 2.06 | -0.066 | 0.309 | 0.038 | 0.001 |
| Financing Cash Flow Items | 2.56 | 8.81 | 0.431 | 0.381 | -0.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50.8 | 8.81 | -4.08 | 3.44 | 11 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.8 | -23.1 | -18.1 | -1.24 | 4.67 |